MRI, Targeted Biopsy, Intervention and Biomarkers in Prostate Cancer Management
UCLA Meyer & Renee Luskin Conference Center
UCLA Campus
Los Angeles, California
September 09, 2016 to September 10, 2016
Download: [ PDF ]
Prostate cancer is the second most common solid organ malignancy diagnosed in men. Unlike other solid organ malignancies, the challenge in prostate cancer is to confidently identify men with moderate and high grade cancers who would most benefit from aggressive therapy. Uniquely among solid organ cancers, imaging has not been a traditional part of the workup of prostate cancer, which has relied instead on transrectal US-guided template biopsy. MR imaging has emerged as the best imaging modality to detect, grade and stage prostate cancer, especially with the introduction of PI-RADS v2. This unique one-and-a-half-day course will provide a comprehensive overview of the utility of multiparametric MR imaging for prostate cancer diagnosis. We will discuss all relevant MR imaging parameters for prostate cancer (T2, perfusion, diffusion, and spectroscopy) as well as new standardized MR reporting algorithms for prostate cancer. In conjunction with the UCLA Departments of Urology, Pathology, Nuclear Medicine, and Radiation Oncology and other world renowned speakers, we will review application of MR imaging in surgical planning for robotic prostatectomy, prostate biopsy planning, active surveillance and radiation planning. We will also discuss state-of-the-art MR targeted biopsy, focal therapy and emerging biomarkers.
Target Audience
Radiologists, urologists, radiation oncologists and family practitioners interested in understanding prostate MR imaging and its applications to active surveillance, biopsy planning and acquisition, surgical planning and radiation planning.
Enrollment
Enrollment in this seminar is limited, so we suggest you enroll early.
Online
To enroll click here
By Mail
Send the completed enrollment form to:
David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
MRI, Targeted Biopsy, Intervention and Biomarkers in Prostate Cancer Management
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512
By FAX
Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.
By Phone
Use your MasterCard, VISA, American Express or Discover card. Call (310) 794-2620.
Registration Fee
- $300.00 - MD Early bird (by July 31, 2016)
- $325.00 - MD (beginning August 1, 2016)
- $200.00 - Fellows/Residents/Techs
Refunds
Cancellations must be received in writing by Friday, August 12, 2016 and will be subject to a $50 processing fee. No refunds will be granted after the cutoff date. If, for any reason, the course must be canceled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.
Course Director
Steven S. Raman, MD
Professor of Radiology, Urology and Surgery
David Geffen School of Medicine at UCLA Faculty
Johannes Czernin, MD
Professor of Molecular and Medical Pharmacology
Dieter Enzmann, MD
Professor of Radiology
Leo G. Rigler Chair, Department of Radiology
Isla Garraway, MD
Assistant Professor of Urology
Mitchell Kamrava, MD
Assistant Professor of Radiation Oncology
Teresa Kyles
Assistant Director
Patient Communication Center Financial Services
David S. K. Lu, MD
Professor of Radiology and Surgery
Daniel J. Margolis, MD
Associate Professor of Radiology
Leonard Marks, MD
Professor of Urology
Justin McWilliams, MD
Assistant Professor of Radiology
Glenn Nyborg
MR Technologist
Department of Radiology
Robert Reiter, MD
Professor of Urology
Director of UCLA Prostate SPORE
Nelly Tan, MD
Clinical Instructor in Radiology
Albert Thomas, PhD
Professor of Radiology
Guest Faculty
Hashim U. Ahmed, PhD, BM, BCh
Honorary Consultant Urological Surgeon, UCLH
Director, Prostate Clinical & Research Programme
Duke Bahn, MD
Diagnostic Radiology
Medical Director, Prostate Institute of America
Jiaoti Huang, MD, PhD
Chairman Department of Pathology
Duke University School of Medicine
Laurence Klotz, MD, FRCS(C)
Professor of Surgery
University of Toronto
Friday, September 9, 2016 |
|
| 8:00 |
Welcome and Introduction - Basics of Prostate MR Imaging Steven S. Raman, MD |
| 8:20 |
T2/Anatomy Daniel J. Margolis, MD |
| 8:35 |
Diffusion & Perfusion Daniel J. Margolis, MD |
| 8:50 |
MR Spectroscopy Albert Thomas, PhD |
| 9:00 |
Case 1: Active Surveillance Steven S. Raman, MD |
| 9:05 |
Active Surveillance & MRI Laurence Klotz, MD |
| 9:30 |
Active Surveillance & Targeted Fusion Biopsy Leonard Marks, MD |
| 10:00 |
MRI-Guided Fusion Biopsy David S. K. Lu, MD |
| 10:15 | Break |
| 10:45 |
Case 2: Surgical Planning Steven S. Raman, MD |
| 10:50 |
Indications for Prostate MRI Daniel J. Margolis, MD |
| 11:00 |
Prostate Pathology Jiaoti Huang, MD, PhD |
| 11:30 |
Prostate Artery Embolization Justin McWilliams, MD |
| 11:45 | Panel Discussion |
| 12:15 | Lunch |
| 1:15 |
Surgical Planning with Prostate MRI Robert Reiter, MD |
| 1:45 |
Pro Focal Therapy Hashim U. Ahmed, PhD, BM, BCH Con Focal Therapy Robert Reiter, MD |
| 2:15 |
Prostate Cryoablation Duke Bahn, MD |
| 2:30 |
Prostate High Intensity Focused Ultrasound Hashim U. Ahmed, PhD, BM, BCh |
| 2:45 |
Laser Ablation Leonard Marks, MD |
| 3:00 |
Emerging Ablative Therapies Laurence Koltz, MD, Steven S. Raman, MD |
| 3:30 | Panel Discussion |
| 4:00 | Adjourn |
Saturday, September 10, 2016 |
|
| 8:00 |
Radiogenomics and RadPath Steven S. Raman, MD |
| 8:10 |
Utility of Prostate Biomarkers Isla Garraway, MD |
| 8:40 |
PI-RADS v2 as an Imaging Biomarker Daniel J. Margolis, MD |
| 8:50 |
Prostate Cancer RadPath Imaging Atlas Daniel J. Margolis, MD |
| 9:00 |
Building a Predictive Model Nelly Tan, MD |
| 9:15 |
Imaging as a Predictive Biomarker UCLA Perspective Daniel J. Margolis, MD Toronto Perspective Laurence Klotz, MD |
| 9:45 | Panel Discussion |
| 10:00 | Break (Discussion Continues) |
| 10:30 |
Case 3: MRI in Radiation Therapy and MRI in Focal Therapy Steven S. Raman, MD |
| 10:35 |
MRI for Radiation Therapy & Focal Therapy Daniel J. Margolis, MD |
| 10:45 |
MRI in XRT Mitchell Kamrava, MD |
| 11:15 |
Nuclear Medicine for Prostate Cancer Matthias Eiber, MD |
| 11:45 |
Imaging for Biochemical Recurrence Daniel J. Margolis, MD |
| 12:00 |
Patient Experience Glenn Nyborg |
| 12:15 |
Insurance and Billing Teresa Kyles |
| 12:30 | Adjourn |
Friday, September 9, 2016 - (Non-CME Accredited Session) |
|
| 3:45 - 5:00 |
Complimentary Hands-on Session The hands-on session will provide a valuable learning opportunity, though no CME credit will be issued for this portion of the program. The hands-on session is complimentary and will give participants an opportunity to work with trainers who will demonstrate the use of each system (i.e. cryoablation, targeted biopsy, HIFU, image analysis). Attendees will also be able to learn from each supporting vendor on each of the current platforms available.The hands-on session will provide a valuable learning opportunity, though no CME credit will be issued for this portion of the program. The hands-on session is complimentary and will give participants an opportunity to work with trainers that will demonstrate the use of each system (i.e. cryoablation, targeted biopsy, HIFU, image analysis). Attendees will also be able to learn from each supporting vendor on each of the current platforms available. |
At the conclusion of this course, participants should be better able to:
- Describe the use of the multiparametric MRI and post processing for state-of-the-art imaging of prostate cancer
- Recognize the utility of multiparametric MRI for active surveillance, biopsy planning, prostatectomy, and radiation therapy planning
- Understand standardized reporting – PI-RADS v2
- Utilize MRI-based targets for prostate cancer biopsy and therapy
- Identify imaging and genomic biomarkers for prostate cancer prognosis
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.
UCLA Meyer & Renee Luskin Conference Center
425 Westwood Plaza
Los Angeles, CA 90095
855-522-8252
www.luskinconferencecenter.ucla.edu
Luskin Conference Center
The Luskin Conference Center features 254 beautifully-appointed guest rooms, many with sweeping views of the stunning campus architecture and beautifully landscaped grounds. The gracious guest experience at the Luskin Conference Center is further enhanced by a full-service restaurant and lounge, on-site professional catering services, well-equipped fitness center, concierge service, business center, and free Wi-Fi throughout the property.
UCLA has arranged a room block at the Luskin Conference Center for our guests. A room rate of $225.00 will be offered (tax exempt). To reserve a room, please contact the Luskin Conference Center after June 1st and indicate you will be attending the UCLA Prostate MRI program. Once the room block is filled, room rates will be subject to availability.
Directions and Parking
From the 405 freeway, exit Wilshire Blvd., East toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on Structure 8 driveway. Drive up the ramp to the rooftop level to park. Parking attendants will be selling permits from 6:30 AM - 8:30 AM each day. If you arrive outside of this time frame, please visit the parking kiosk on Westwood Plaza to pay for your parking permit. Participants are responsible for their own parking charges at a rate of $12 per vehicle. The Luskin Conference Center is located at Westwood Plaza and Strathmore Place.